WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for ATHA

Based on 3 analysts offering 12 month price targets for Athira Pharma Inc.
Min Forecast
$5.00+152.53%
Avg Forecast
$11.33+472.37%
Max Forecast
$19.00+859.6%

Should I buy or sell ATHA stock?

Based on 3 analysts offering ratings for Athira Pharma Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHA stock forecasts and price targets.

ATHA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JMP Securities
Bottom 5%
5
BuyMaintains$19.00+859.60%2023-08-11
Mizuho
Bottom 4%
4
Strong BuyMaintains$5.00+152.53%2023-05-15
BTIG
Bottom 6%
6
Strong BuyMaintains$10.00+405.05%2023-03-30

1 of 1

Forecast return on equity

Is ATHA forecast to generate an efficient return?
Company
N/A
Industry
30.53%
Market
58.62%

Forecast return on assets

Is ATHA forecast to generate an efficient return on assets?
Company
N/A
Industry
12.12%

ATHA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHA$1.98$11.33+472.37%Strong Buy
EVLO$3.99$10.00+150.63%Hold
CRVS$1.53$5.83+281.24%Strong Buy
KRON$1.30$9.00+592.31%Buy
YS$0.82N/AN/A

Athira Pharma Stock Forecast FAQ

Is Athira Pharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ATHA) stock is to Strong Buy ATHA stock.

Out of 3 analysts, 2 (66.67%) are recommending ATHA as a Strong Buy, 1 (33.33%) are recommending ATHA as a Buy, 0 (0%) are recommending ATHA as a Hold, 0 (0%) are recommending ATHA as a Sell, and 0 (0%) are recommending ATHA as a Strong Sell.

If you're new to stock investing, here's how to buy Athira Pharma stock.

What is ATHA's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: ATHA) forecast ROE is N/A, which is considered weak.

What is ATHA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ATHA price target, the average ATHA price target is $11.33, with the highest ATHA stock price forecast at $19.00 and the lowest ATHA stock price forecast at $5.00.

On average, Wall Street analysts predict that Athira Pharma's share price could reach $11.33 by Aug 11, 2024. The average Athira Pharma stock price prediction forecasts a potential upside of 472.37% from the current ATHA share price of $1.98.

What is ATHA's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: ATHA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 12.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.